TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,278,619 | +4.7% | 211,934 | +6.3% | 0.00% | +50.0% |
Q2 2023 | $3,130,799 | +10.9% | 199,287 | +15.4% | 0.00% | 0.0% |
Q1 2023 | $2,824,201 | +17.7% | 172,734 | +12.3% | 0.00% | 0.0% |
Q4 2022 | $2,399,592 | -88.9% | 153,820 | -90.7% | 0.00% | -89.5% |
Q3 2022 | $21,527,000 | +1397.0% | 1,659,743 | +1520.4% | 0.02% | +1800.0% |
Q2 2022 | $1,438,000 | +41.8% | 102,425 | +44.7% | 0.00% | 0.0% |
Q1 2022 | $1,014,000 | +20.3% | 70,780 | +14.5% | 0.00% | 0.0% |
Q4 2021 | $843,000 | -9.5% | 61,839 | +8.7% | 0.00% | 0.0% |
Q3 2021 | $932,000 | -2.7% | 56,894 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $958,000 | +84.2% | 56,894 | +99.9% | 0.00% | – |
Q1 2021 | $520,000 | +23.8% | 28,458 | +23.3% | 0.00% | – |
Q4 2020 | $420,000 | +25.7% | 23,078 | +23.1% | 0.00% | – |
Q3 2020 | $334,000 | +2.1% | 18,744 | +2.6% | 0.00% | – |
Q2 2020 | $327,000 | +66.8% | 18,262 | +41.3% | 0.00% | – |
Q1 2020 | $196,000 | – | 12,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |